You can buy or sell BHVN and other stocks, options, ETFs, and crypto commission-free!
Biohaven Pharmaceutical Holding Company Ltd., also called Biohaven Pharmaceutical, is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. Read More The company was founded in September 2013 and is headquartered in New Haven, CT.
New Haven, Connecticut
52 Week High
52 Week Low
BRIEF-Biohaven Pharmaceutical Says If This Planned Vazegepant Phase 3 Trial Is Positive, Would Have Potential Of Filing An NDA Next Year
March 23 (Reuters) - Biohaven Pharmaceutical Holding Company Ltd: * BIOHAVEN PHARMACEUTICAL HOLDING COMPANY - IF THIS PLANNED VAZEGEPANT PHASE 3 TRIAL IS POSIT
— per share
Expected May 5, Pre-Market